HomeAGNPF • OTCMKTS
add
Algernon Pharmaceuticals Inc
Previous close
$0.054
Day range
$0.059 - $0.063
Year range
$0.038 - $0.12
Market cap
2.19M CAD
Avg Volume
6.30K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Aug 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 379.40K | -60.11% |
Net income | -421.43K | 83.32% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -373.99K | 60.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Aug 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 596.20K | 376.63% |
Total assets | 3.94M | -5.95% |
Total liabilities | 1.78M | -34.72% |
Total equity | 2.17M | — |
Shares outstanding | 21.30M | — |
Price to book | 0.67 | — |
Return on assets | -24.20% | — |
Return on capital | -45.92% | — |
Cash Flow
Net change in cash
| (CAD) | Aug 2024info | Y/Y change |
|---|---|---|
Net income | -421.43K | 83.32% |
Cash from operations | -632.49K | -10.44% |
Cash from investing | -4.03K | 27.75% |
Cash from financing | 628.02K | 133.32% |
Net change in cash | -13.33K | 95.69% |
Free cash flow | -483.70K | -76.87% |
About
Founded
2015
Headquarters
Website
